Ballentine Partners LLC Makes New $131,000 Investment in Clover Health Investments, Corp. (NASDAQ:CLOV)

Ballentine Partners LLC purchased a new position in Clover Health Investments, Corp. (NASDAQ:CLOV) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 41,496 shares of the company’s stock, valued at approximately $131,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Forum Financial Management LP lifted its holdings in shares of Clover Health Investments by 33.8% during the third quarter. Forum Financial Management LP now owns 16,077 shares of the company’s stock valued at $45,000 after purchasing an additional 4,061 shares in the last quarter. Steph & Co. increased its stake in shares of Clover Health Investments by 33.3% in the fourth quarter. Steph & Co. now owns 20,000 shares of the company’s stock worth $63,000 after purchasing an additional 5,000 shares in the last quarter. SignalPoint Asset Management LLC boosted its stake in shares of Clover Health Investments by 6.2% in the fourth quarter. SignalPoint Asset Management LLC now owns 160,074 shares of the company’s stock worth $504,000 after acquiring an additional 9,390 shares during the period. Bleakley Financial Group LLC grew its stake in Clover Health Investments by 98.9% during the third quarter. Bleakley Financial Group LLC now owns 20,090 shares of the company’s stock valued at $57,000 after acquiring an additional 9,988 shares in the last quarter. Finally, Concurrent Investment Advisors LLC purchased a new position in Clover Health Investments during the 3rd quarter valued at approximately $28,000. 19.77% of the stock is currently owned by institutional investors.

Clover Health Investments Price Performance

NASDAQ CLOV opened at $4.82 on Monday. The stock’s fifty day moving average price is $3.48 and its 200 day moving average price is $3.12. Clover Health Investments, Corp. has a 1 year low of $0.61 and a 1 year high of $4.87. The company has a market cap of $2.42 billion, a price-to-earnings ratio of -24.10 and a beta of 1.95.

Clover Health Investments (NASDAQ:CLOV) last posted its quarterly earnings results on Wednesday, November 6th. The company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.03) by $0.01. The company had revenue of $330.99 million for the quarter, compared to analyst estimates of $347.60 million. Clover Health Investments had a negative net margin of 5.92% and a negative return on equity of 25.46%. During the same period in the prior year, the company earned ($0.09) earnings per share. Research analysts expect that Clover Health Investments, Corp. will post -0.12 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on CLOV shares. Craig Hallum began coverage on Clover Health Investments in a research report on Tuesday, December 17th. They set a “buy” rating and a $6.00 target price on the stock. UBS Group started coverage on Clover Health Investments in a research note on Monday, October 7th. They set a “neutral” rating and a $4.00 price objective for the company.

Clover Health Investments Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.